HNPMA did not change the protein levels of the potency-associated markers (OCT4 and SOX2) but addition of extracellular IGFBP-6 with […]
Targeting FLT3 for Cancer therapy
FLT3 inhibitors
HNPMA did not change the protein levels of the potency-associated markers (OCT4 and SOX2) but addition of extracellular IGFBP-6 with […]